Dr. Tim Rebbeck is Professor Epidemiology at the TH Chan School of Public Health, Harvard, and Professor of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Rebbeck leads molecular epidemiology studies of cancer etiology, outcomes, health disparities, and global health. His work has led to an understanding of the genetic and environmental causes of breast, prostate, skin, endometrial and ovarian cancers. Dr. Rebbeck founded and leads international cancer consortia that study risk and outcomes of 1) cancer in BRCA1/BRCA2 mutation carriers, and 2) prostate cancer in men of African descent in North America, the Caribbean, and Africa. Prior to joining Harvard and the Dana-Farber Cancer Institute, Dr. Rebbeck served as the Director of the Center for Genetics and Complex Traits at the Perelman School of Medicine, University of Pennsylvania. Dr. Rebbeck received his PhD in Human Genetics from the University of Michigan.